The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Persistence of Increased Cardiovascular Risk in Patients with Cushing's Disease after Five Years of Successful Cure
Abstract
Patients with Cushing's disease (CD) mainly die because of cardiovascular accidents. The aim of this study was to evaluate whether patients with CD still have increased cardiovascular risk and suffer from premature atherosclerosis once cured. Fifteen patients cured from CD for a long term period (5 yr), 30 sex-and age-matched controls, and 30 body mass index (BMI)-matched controls were included in this study. BMI; waist to hip ratio (WHR); systolic (SBP) and diastolic (DBP) blood pressures; serum total, low density lipoprotein (LDL), and high density lipoprotein (HDL) cholesterol; serum triglycerides, fibrinogen, and lipoprotein(a) levels; prothrombin time; activated partial thromboplastine time; and basal and glucose load-stimulated insulin and glucose levels were measured in patients and controls. By echo-Doppler ultrasonography, the intima media thickness (IMT), systolic and diastolic media-media distances, blood systolic (SPV) and diastolic (DPV) peak velocity, systolic (SLD) and diastolic (DLD) lumen diameter, and distensibility coefficient (DC) were measured at both common carotid arteries where the presence, size, and location of atherosclerotic plaques were also evaluated. Compared with a sex- and age-matched control population, CD patients had BMI (P < 0.001), WHR (P < 0.001), SBP (P < 0.005), DBP (P < 0.05), fasting glucose (P < 0.001) and insulin (P < 0.05), glucose load-stimulated glucose and insulin levels (P < 0.05), total cholesterol (P < 0.05), LDL cholesterol (P < 0.01), fibrinogen (P < 0.01), and lipoprotein(a) (P < 0.05) levels higher and HDL cholesterol levels (P < 0.05) lower than controls. At ultrasonography, in the patients, IMT (P < 0.05), SPV (P < 0.05) and DPV (P < 0.001) were significantly increased whereas SLD (P < 0.001), DLD (P < 0.001), and DC (P < 0.05) were significantly decreased compared to controls. In addition, CD patients had higher WHR (P < 0.05), DBP (P < 0.05), glucose load-stimulated glucose and insulin levels (P < 0.05), and fibrinogen levels (P < 0.01) and lower HDL cholesterol (P < 0.05) levels than BMI-matched controls. At ultrasonography, increased common carotid arteries IMT (P < 0.05) and DPV (P < 0.05) and decreased DLD (P < 0.05) and DC (P < 0.05) were measured in patients compared to those in BMI-matched controls. Atherosclerotic plaques were found in 26.7% of patients, in none of the sex- and age-matched controls, and in 3.3% of the BMI-matched controls. In CD patients, a significant correlation was found between both WHR and fasting serum insulin levels and DBP (r = 0.52 and r = 0.55; P < 0.05), triglycerides levels (r = 0.56 and r = 0.77; P < 0.05), and IMT (r = 0.64 and r = 0.56; P < 0.05). Right (r = -0.70; P < 0.005) and left (r = -0.65; P < 0.01) DC were inversely correlated to the duration of CD in the patient group. At the multiple regression analysis, WHR was the best predictor of fasting insulin levels (beta = 0.77; P < 0.05), and vice versa, fasting insulin level was the best predictor of WHR (beta = 1.20; P < 0.05). In conclusion, patients cured from CD for a long term period have a high prevalence of atherosclerosis and maintain increased several cardiovascular risk factors of the active disease, probably due to a residual abdominal obesity and/or insulin resistance syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Williams Textbook of Endocrinology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,711
Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.
Pignoli, P., Tremoli, E., Poli, A., Oreste, P., & Paoletti, R. (1986) · Circulation · doi:10.1161/01.cir.74.6.1399 · Cited by 2,404
Goodman, D. S. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010040006 · Cited by 2,246
Ohlson, L. O., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,020
The natural history of cushing's syndrome
Plotz, C. M., Knowlton, A. I., & Ragan, C. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90027-2 · Cited by 763
; (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.379 · Cited by 655
Morbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622
Lipoprotein (a). Heterogeneity and biological relevance.
Scanu, A. M., & Fless, G. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114625 · Cited by 573
[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Markussis, V., Beshyah, S. A., Johnston, D. G., Fisher, C., Nicolaides, A. N., & Sharp, P. (1992) · The Lancet · doi:10.1016/0140-6736(92)92892-j · Cited by 390
Splanchnic insulin metabolism in obesity. Influence of body fat distribution.
Peiris, A. N., Mueller, R. A., Smith, G. A., Struve, M. F., & Kissebah, A. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112758 · Cited by 346
Trainer, P. J., Lawrie, H. S., Verhelst, J., Howlett, T. A., Lowe, D. G., Grossman, A. B., Savage, M. O., Afshar, F., & Besser, G. M. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00975.x · Cited by 267
TROXLER, R., SPRAGUE, E., ALBANESE, R., FUCHS, R., & THOMPSON, A. (1977) · Atherosclerosis · doi:10.1016/0021-9150(77)90098-3 · Cited by 219
Adrenal glucocorticoids after twenty years
David, D. S., Grieco, M. H., & Cushman, P. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90078-0 · Cited by 209
Gamble, G., Zorn, J., Sanders, G., MacMahon, S., & Sharpe, N. (1994) · Stroke · doi:10.1161/01.str.25.1.11 · Cited by 204
Is atherosclerosis a complication of long-term corticosteroid treatment?
Nashel, D. J. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90639-x · Cited by 181
Book Review: Obesity: A Report of the Royal College of Physicians
Yudkin, J. (1983) · Journal of the Royal Society of Medicine · doi:10.1177/014107688307600624 · Cited by 180
Guilhaume, B., BERTAGNA, X. Y., THOMSEN, M., Bricaire, C., Vila‐Porcile, É., Olivier, L., Racadot, J., Derome, P., Laudat, M. H., Girard, F., et al. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-5-1056 · Cited by 150
Obesity. Part I--Pathogenesis.
Bray, G. A., & Gray, D. S. (1988) · PubMed Central · Cited by 149
Obesity and cardiovascular disease
Sowers, J. R. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1821 · Cited by 141
Assessment of endocrine function after transsphenoidal surgery for Cushing's disease
McCance, D. R., Gordon, D. S., Fannin, T. F., Hadden, D. R., Kennedy, L., Sheridan, B., & Atkinson, A. B. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00976.x · Cited by 123
Abdominal obesity and its metabolic complications
Lamarche, B. (1998) · Coronary Artery Disease · doi:10.1097/00019501-199809080-00002 · Cited by 122
TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE: DOES WHAT IS REMOVED DETERMINE THE ENDOCRINE OUTCOME?
Burke, C. W., Adams, C. B. T., Esiri, M. M., Morris, C. S., & Bevan, J. S. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb03890.x · Cited by 120
Kalbak, K. (1972) · Annals of the Rheumatic Diseases · doi:10.1136/ard.31.3.196 · Cited by 107
Colao, A., Cerbone, G., Pivonello, R., Aimaretti, G., Loche, S., Somma, C. D., Faggiano, A., Corneli, G., Ghigo, E., & Lombardi, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5605 · Cited by 102
Self-citationCoronary atherosclerosis and myocardial infarction associated with systemic lupus erythematosus
Tsakraklides, V., Blieden, L. C., & Edwards, J. E. (1974) · American Heart Journal · doi:10.1016/0002-8703(74)90504-3 · Cited by 95
Assessment of cure after transsphenoidal surgery for Cushing's disease
McCance, D., Besser, M., & Atkinson, A. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.614436.x · Cited by 78
Kaur, K., & Findling, J. W. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-103-5_3 · Cited by 70
Boyko, E. J., Leonetti, D. L., Bergstrom, R. W., Newell-Morris, L., & Fujimoto, W. Y. (1996) · Diabetes · doi:10.2337/diab.45.8.1010 · Cited by 61
ACTH-Producing Pituitary Tumors
Grua, J. R., & Nelson, D. H. (1991) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30271-8 · Cited by 50
A practical approach to treatment of the obese patient
Yanovski, J. A. (1993) · Archives of Family Medicine · doi:10.1001/archfami.2.3.309 · Cited by 46
Stamler, J., Pick, R. L., & Katz, L. N. (1954) · Circulation · doi:10.1161/01.cir.10.2.237 · Cited by 41
Persistent hypertension after successful adrenal operation.
Simon, D., Goretzki, P. E., Lollert, A., & Röher, H.-D. (1993) · PubMed · Cited by 33
Enhancement of Experimental Atherosclerosis by ACTH in the Dog.
Rosenfeld, S., Marmorston, J., Sobel, H., & White, A. (1960) · Experimental Biology and Medicine · doi:10.3181/00379727-103-25420 · Cited by 30
Bray, G. A., & Gray, D. S. (1988) · PubMed Central · Cited by 21
Insulin Resistance in Cushing's Syndrome
Karnieli, E., Cohen, P., Barzilai, N., Ish-Shalom, Z., Armoni, M., Rafaelov, R., & Barzilai, D. (1985) · Hormone and Metabolic Research · doi:10.1055/s-2007-1013593 · Cited by 17
Lorenzen, I., & Lk, H. (1967) · PubMed · Cited by 9
Cited by
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
“Because markers of cardiovascular risk remain abnormal for up to 5 yr after surgery, further studies are needed to assess long-term SMR (14).”
BackgroundInfluentialLacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
Sgk1-Dependent Stimulation of Cardiac Na+/H+Exchanger Nhe1 by Dexamethasone
Voelkl, J., Pasham, V., Ahmed, M. S. E., Walker, B., Szteyn, K., Kuhl, D., Metzler, B., Alesutan, I., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350120 · Cited by 857
Metadata
- Authors
- Colao, A.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-08-01
- Volume
- 84
- Issue
- 8
- Pages
- 2664-2672
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W1995365748
- Cited by
- 450
- References
- 38
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.